Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-820 for Resistant Pruritus in Hemodialysis Patients
NCT01513161Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Apr 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalfurafine in pruritus, sponsored by SK Chemicals. Started Apr 2008; status: completed.
02
Drugs
nalfurafine
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT01513161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513161.